SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-049184
Filing Date
2018-08-02
Accepted
2018-08-02 16:09:08
Documents
8
Period of Report
2018-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-18192_28k.htm 8-K 38947
2 EX-4.1 a18-18192_2ex4d1.htm EX-4.1 105296
3 EX-4.2 a18-18192_2ex4d2.htm EX-4.2 118613
4 EX-5.1 a18-18192_2ex5d1.htm EX-5.1 14226
5 EX-10.1 a18-18192_2ex10d1.htm EX-10.1 254359
6 EX-99.1 a18-18192_2ex99d1.htm EX-99.1 13363
7 GRAPHIC g181922mmi001.jpg GRAPHIC 6298
8 GRAPHIC g181922kki001.jpg GRAPHIC 3224
  Complete submission text file 0001104659-18-049184.txt   559502
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 18988354
SIC: 3845 Electromedical & Electrotherapeutic Apparatus